Takafumi Kitazono, Taichi Isobe, Satoshi Nishiyori, Wataru Kusano, Kenro Tanoue, Tomoyasu Yoshihiro, Hirofumi Ohmura, Kyoko Yamaguchi, Mamoru Ito, Kenji Tsuchihashi, et al. Metastatic urachal carcinoma treated with trifluridine/tipiracil and bevacizumab: a case report. International Cancer Conference Journal. 2025
Tomoyasu Yoshihiro, Kyoko Yamaguchi, Hiroshi Ariyama, Sakuya Koreishi, Koki Uehara, Hirofumi Ohmura, Mamoru Ito, Kenji Tsuchihashi, Taichi Isobe, Koji Shindo, et al. Elucidation of the mechanism of carcinogenic transformation of human gastric epithelial cells in atrophic gastritis. Biochimica et biophysica acta. Molecular basis of disease. 2025. 1871. 6. 167843-167843
K. Yamaguchi, K. Tsuchihashi, S. Ueno, K. Uehara, R. Taguchi, M. Ito, T. Isobe, T. Imajima, T. Kitazono, K. Tanoue, et al. Efficacy of pembrolizumab in microsatellite-stable, tumor mutational burden-high metastatic colorectal cancer: genomic signatures and clinical outcomes. ESMO Open. 2025
Kenro Tanoue, Hirofumi Ohmura, Koki Uehara, Mamoru Ito, Kyoko Yamaguchi, Kenji Tsuchihashi, Yudai Shinohara, Peng Lu, Shingo Tamura, Hozumi Shimokawa, et al. Spatial dynamics of CD39+CD8+ exhausted T cell reveal tertiary lymphoid structures-mediated response to PD-1 blockade in esophageal cancer. Nature communications. 2024. 15. 1. 9033-9033
Takashi Matsumura, Kenji Tsuchihashi, Takeo Yamamoto, Fumiaki Jinnouchi, Wataru Kusano, Yota Kusumoto, Kohei Arimizu, Hirofumi Ohmura, Yuki Kuma, Shohei Moriyama, et al. Lymphoproliferative Disorder in an Esophageal Cancer Patient Treated with Pembrolizumab. Internal medicine (Tokyo, Japan). 2024